about
Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid raftsMitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole.A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration.Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.UPDATE ON DEMENTIA WITH LEWY BODIES.Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles.The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.Neuropathological investigation of dementia: a guide for neurologists.Rivastigmine in Parkinson's disease dementia.Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.Car drivers with dementia: Different complications due to different etiologies?BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review.Parkinson disease with and without Dementia: A prevalence study and future projections.Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
P2860
Q28742804-7A7C2C12-5E95-4ED7-A7E4-70DF77CD6B5FQ33529864-61449E3B-C011-4424-AB11-C93C68288968Q33982546-D34EE3F2-CC23-4958-990E-C4F34E7CA1ECQ34238665-3D70813A-CFB9-450E-83BB-A29A2B7011E0Q34450376-A747F4CA-2A2D-465A-8E28-9FCA74F35E41Q34575656-4B28A2B0-4843-4B4C-B74B-C70E6BE17E55Q34811582-E77DB99A-123F-4864-929B-9B237C200D0DQ35427654-7FADC5C9-5811-4912-9A8F-69F85522872EQ35488511-6099C473-AC7D-4867-A928-450831A8A55EQ36314480-A5679A55-1A12-44D7-9973-03E82D3A9562Q37232006-8E52C889-F44C-4879-A825-BB0A3111A4EFQ37592662-6FC11D74-07AF-412A-B7C7-753B7F6D86D7Q38421354-EF31A35D-6149-41B6-8AE7-FD0C8565D2B0Q46249334-CD301F75-D274-45F6-91A2-E02BE22F95FAQ47646972-1CB817A2-D910-432C-9434-1CBD78450D11Q47720092-9061BEE8-BD6E-41A6-BEE3-68EDBD47B6F2Q48134401-0EA39537-CD51-49F7-84D8-5BDA73318CE1Q48298020-50C42488-2D8F-46A3-8CC2-C0CFB9B4533EQ48328107-37CAB0B6-A492-4C45-A959-3A8E9C202986Q48702441-F8AFE88B-78A1-4547-9940-5F9AF69268AEQ49987358-D35ED7F7-D3D3-4DAE-A6FD-20D363565582Q53391751-2F47E213-CD63-461B-B4D8-246BA9F12B74Q54982491-FEEAC1FA-477E-4EDA-AC95-7CE254AA6B9A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dementia with Lewy bodies and Parkinson's disease.
@ast
Dementia with Lewy bodies and Parkinson's disease.
@en
type
label
Dementia with Lewy bodies and Parkinson's disease.
@ast
Dementia with Lewy bodies and Parkinson's disease.
@en
prefLabel
Dementia with Lewy bodies and Parkinson's disease.
@ast
Dementia with Lewy bodies and Parkinson's disease.
@en
P1476
Dementia with Lewy bodies and Parkinson's disease
@en
P2093
McKeith IG
Mosimann UP
P356
10.1016/J.PARKRELDIS.2003.12.005
P478
10 Suppl 1
P577
2004-05-01T00:00:00Z